Legend Biotech develops cell therapies for cancer, with a pipeline spanning hematologic malignancies and solid tumors.

This clinical-stage biotech targets RAS/MAPK pathway cancers with a pipeline of novel small molecule oncology therapies.

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...

Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...

This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and ...

Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm. Following a robust rally, Moderna appears to be regaining leadership within the biotech space. This ...

Humacyte is cutting about a quarter of its workforce as it revamps its commercial strategy. Durham biotech's breakthrough ...

Kyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the ...

MBC BioLabs sees its two biotech incubators location in San Francisco's Dogpatch neighborhood, near the AI hub of Mission Bay, as an advantage. It wants to build one more to prove the point.

Isomorphic Labs, which hasn’t yet disclosed a molecule or reached the clinic, breaks the recent trend of investors putting ...

Legend Biotech Corp LEGN reported downbeat results for the first quarter on Tuesday. The company posted quarterly losses of 3 ...

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...